The Patent Finder

PeptiMed, Inc.

Also on record
Records under this name other than the patents PeptiMed, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 3 of 3 · Back to PeptiMed, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,680,045Compositions of a peptide targeting system for treating cancer
Lapsed on the fee record
Ended Mar 25, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 25, 2026USPTO record
US 10,111,898Anti-tumor compositions and methods
Lapsed on the fee record
Ended Oct 30, 2022 · USPTO record
Lapsed on the fee recordEnded Oct 30, 2022USPTO record
US 5,885,956Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand
Formerly held
Term ended
Term ended no later than Mar 23, 2019 · Low confidence
Term endedTerm ended no later than Mar 23, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited